Where does PrognomIQ's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across PrognomIQ's 3 recorded funding rounds.

Premier Alternatives

PrognomIQ

San Mateo, CA · Founded 2020 · Privately Held (backing)

Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. PrognomIQ is based in San Mateo, CA and was founded in 2020. It is valued at about $316 million as of Oct 2026, set by institutional fund marks. It has raised $172 million across 3 recorded rounds; the latest was an $11.9 million early-stage round in Jan 2026.

PMV mark · valuation

$315.6M

Oct 2026

Priced at

—

Total raised

$171.8M

Last round

Early Stage VC

Jan 2026

Cap table — not yet on record

PrognomIQ's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on PrognomIQ

·5 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about PrognomIQ

Where does PrognomIQ's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across PrognomIQ's 3 recorded funding rounds.